Axa’s KEMET Corporation KEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-156,400
Closed -$2.74M 1443
2018
Q4
$2.74M Sell
156,400
-33,800
-18% -$632K 0.01% 757
2018
Q3
$3.53M Sell
190,200
-16,600
-8% -$409K 0.01% 755
2018
Q2
$4.99M Sell
206,800
-89,900
-30% -$1.83M 0.02% 656
2018
Q1
$5.38M Hold
296,700
0.02% 630
2017
Q4
$4.47M Buy
296,700
+230,701
+350% +$4.39M 0.02% 683
2017
Q3
$1.4M Buy
65,999
+44,099
+201% +$834K 0.01% 895
2017
Q2
$280K Buy
+21,900
New +$278K ﹤0.01% 1155
2014
Q4
Sell
-14,600
Closed -$60K 1562
2014
Q3
$60K Hold
14,600
﹤0.01% 1342
2014
Q2
$84K Buy
14,600
+12,200
+508% +$67.8K ﹤0.01% 1303
2014
Q1
$14K Buy
+2,400
New +$13.7K ﹤0.01% 1373

Other funds holding KEM

Axa's KEM Position: Q1 2019 in Review

Axa sold out of KEMET Corporation (KEM) in Q1 2019, closing a stake of 156,400 shares — an estimated $2.74M sold.

Axa first reported a position in KEM in Q1 2014 and held it in 10 quarters. The position peaked at $5.38M in Q1 2018. 207 funds tracked by Wall St. Rank hold KEM as of Q1 2019.

  • Axa reported no remaining KEMET Corporation position as of Q1 2019 after selling out during the quarter.
  • Axa sold 156,400 KEMET Corporation shares in Q1 2019, an estimated $2.74M.
  • Axa first reported a position in KEMET Corporation in Q1 2014 and held it in 10 quarters.
  • Axa's KEMET Corporation position peaked at $5.38M in Q1 2018.
  • 207 funds tracked by Wall St. Rank held KEMET Corporation as of Q1 2019.

Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.